Skip to content
akaturk Academic measurement
  1. Ana Dal Sağlık Bilimleri Temel Alanı
  2. Yan Dal Göz Hastalıkları
Academic summary YÖKSİS and OpenAlex counted separately.
Articles 28
YÖKSİS28 OpenAlex0
Projects 1
Books 4
Proceedings 17

Citation impact

OpenAlex YÖKSİS articles matched in OpenAlex: 28
h-index 11 Percentile in Türkiye: 88 #552 of 2,324 at their university by h-index
i10-index
11
Total citations
459
Top 12% in Türkiye
Per article
16.4
FWCI
1.79
1.00 = world average
World top 1%
1
World top 10%
3

h-index and citations are computed from the citation counts of this academic’s YÖKSİS articles matched in OpenAlex (not Google Scholar, WoS or Scopus). Unmatched articles are not included.

Field ranking

YÖKSİS ?

Collaboration network

From the author lists of YÖKSİS publication records. Duplicate records of a work count once; institutions are co-authors’ current YÖKSİS affiliations.

Co-authors
43
With an akaturk profile
2
Turkish institutions
0
Co-authored works
%96

Academic co-authors 2

  1. HAYYAM KIRATLI Profesör · Hacettepe Üniversitesi same university 23
  2. GÜRCAN GÜNAYDIN Doçent · Hacettepe Üniversitesi same university 1

National collaboration 0 institutions

Within own university23 joint works · Hacettepe Üniversitesi

No joint work with another Turkish university.

Other co-authors (incl. international) 41

HANDE TAYLAN ŞEKEROĞLU 4ALİ VARAN 3CANAN AKYÜZ 3FİGEN SÖYLEMEZOĞLU 3KADRİYE ERKAN TURAN 3YASEMİN KAPUCU 3ALİ ŞEFİK SANAÇ 2AYŞENUR ELMALI 2BORA ELDEM 2FARUK ZORLU 2GÖKHAN ÖZYİĞİT 2GÖZDE YAZICI 2MUSTAFA CENGİZ 2ORHAN DİCLEHAN 2SİBEL KADAYIFÇILAR 2ÖZGE DELİKTAŞ 2ALİ SANAÇARZU SAĞLAMBERÇİN TARLANDENİZ YÜCEDİLA KIRAĞIDİLAN ÇOLAKEBRU ÖZTÜRKEKİM GÜMELEREMİN CUMHUR ŞENEREMİRHAN NEMUTLUESRA VURALFATMA GÜNDOĞDUHİLAL TOPRAKJALE KARAKAYAKEMAL KÖSEMEHMETOĞLUMELEK TUĞÇE YILMAZMELTEM KILIÇMUSTAFA EMRE GEDİKONUR İNAMSAMİYE YABANOĞLU ÇİFTÇİSELMA YILDIRIMSELÇUK SÜRÜCÜSEPİDEH LOTFİSADİGHSEZİN YÜCE SARI

Show all (41)

ÖZGÜR ÖZKAYAR

Authors without an akaturk profile (international researchers, retired or former academics, students, clinicians) are grouped by name spelling; short forms such as “Gulluce M.” join the single full name they match.

Index quartiles

?
Scopus (SJR) 26
  • Q1 6 %23.1
  • Q2 15 %57.7
  • Q3 3 %11.5
  • Q4 2 %7.7
WoS (JCR) 25
  • Q1 2 %8.0
  • Q2 5 %20.0
  • Q3 10 %40.0
  • Q4 8 %32.0
TR Index 4 articles
OpenAlex citation percentile
Top 1%1
Top 10%3
Avg · n 28 %61.3
Other counts

Scopus (SJR)

  • YÖKSİS rows 26

WoS (JCR)

  • YÖKSİS rows 25

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

28articles

Journals with publications

21 journals

Narrow down

Scopus (SJR)
WoS (JCR)
TR Index

Article list

  1. 2023 Modulation of AMPK Significantly Alters Uveal Melanoma Tumor Cell Viability Ophthalmic Research DOI 10.1159/000533806 YÖKSİS SJR Q2 JCR Q2 OpenAlex 79.5%
  2. 2023 Reaktif Retinal Astrositik Tümörlerde Tedavi ve Takip Sonuçlarımız: Kesitsel Araştırma Türkiye Klinikleri Oftalmoloji Dergisi DOI 10.5336/ophthal.2022-91057 YÖKSİS OpenAlex 6.6%
  3. 2023 Clinical Features and Treatment Results of Conjunctival Melanoma: Cross-Sectional Study Acta Medica DOI 10.32552/2023.ActaMedica.877 YÖKSİS TR Index OpenAlex 5.3%
  4. 2022 The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries LANCET GLOBAL HEALTH DOI 10.1016/S2214-109X(22)00250-9 YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%
  5. 2022 Spontaneous Partial Regression of Bilateral Grade III Corneal Dermoids Associated With Fetal Valproate Spectrum Disorder CORNEA DOI 10.1097/ICO.0000000000002989 YÖKSİS SJR Q1 JCR Q2 OpenAlex 51.2%
  6. 2022 Every other day stereotactic radiation therapy for the treatment of uveal melanoma decreases toxicity RADIOTHERAPY AND ONCOLOGY DOI 10.1016/j.radonc.2022.09.010 YÖKSİS SJR Q1 JCR Q1 OpenAlex 81.8%
  7. 2021 Radiotherapy-induced alterations in vitreous humor: A new potential critical structure EXPERIMENTAL EYE RESEARCH DOI 10.1016/j.exer.2021.108802 YÖKSİS SJR Q1 JCR Q2 OpenAlex 75.9%
  8. 2021 Periocular apocrine adenocarcinoma presenting as an orbital mass: clinicopathological features and management in four patients EUROPEAN JOURNAL OF OPHTHALMOLOGY DOI 10.1177/11206721211029473 YÖKSİS SJR Q2 JCR Q4 OpenAlex 74.2%
  9. 2021 Management of cataracts secondary to intravitreal chemotherapy injections for retinoblastoma seeding EUROPEAN JOURNAL OF OPHTHALMOLOGY DOI 10.1177/11206721211023317 YÖKSİS SJR Q2 JCR Q4 OpenAlex 74.6%
  10. 2020 La maladie d’Erdheim–Chester révélée par une atteinte orbitaire bilatérale : étude de trois cas JOURNAL FRANCAIS D OPHTALMOLOGIE DOI 10.1016/j.jfo.2019.11.045 YÖKSİS SJR Q4 JCR Q4 OpenAlex 51.7%
  11. 2020 Recurrence of a Totally Excised Cavernous Venous Malformation 25 Years Later OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY DOI 10.1097/IOP.0000000000001751 YÖKSİS SJR Q2 JCR Q3 OpenAlex 50.8%
  12. 2020 Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma JAPANESE JOURNAL OF OPHTHALMOLOGY DOI 10.1007/s10384-020-00743-2 YÖKSİS SJR Q2 JCR Q3 OpenAlex 84.5%
  13. 2020 Primary Ciliary Body Marginal Zone Lymphoma Presenting as Hemorrhagic Hypopyon OCULAR IMMUNOLOGY AND INFLAMMATION DOI 10.1080/09273948.2020.1815798 YÖKSİS SJR Q2 JCR Q2 OpenAlex 59.4%
  14. 2020 Current Management of Conjunctival Melanoma Part 2: Treatment and Future Directions The Turkish Journal of Ophthalmology DOI 10.4274/tjo.galenos.2020.22567 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 75.5%
  15. 2020 Current Management of Conjunctival Melanoma Part 1: Clinical Features, Diagnosis and Histopathology The Turkish Journal of Ophthalmology DOI 10.4274/tjo.galenos.2020.38096 YÖKSİS TR Index SJR Q2 JCR Q3 OpenAlex 68.7%
  16. 2019 Intravitreal dexamethasone (ozurdex) implant for radiation maculopathy secondary to stereotactic radiotherapy for posterior uveal melanoma Retinal Cases & Brief Reports DOI 10.1097/ICB.0000000000000593 YÖKSİS SJR Q3 OpenAlex 69.2%
  17. 2018 Retrospective analysis of primarily treated group D retinoblastoma Graefe's Archive for Clinical and Experimental Ophthalmology ( DOI 10.1007/s00417-018-4051-4 YÖKSİS SJR Q1 JCR Q2 OpenAlex 78.3%
  18. 2017 Real-World Results of Intravitreal Ranibizumab, Bevacizumab, or Triamcinolone for Diabetic Macular Edema OPHTHALMOLOGICA DOI 10.1159/000481180 YÖKSİS SJR Q1 JCR Q3 OpenAlex 84.7%
  19. 2017 Intravitreal Chemotherapy in the Management of Vitreous Disease in Retinoblastoma EUROPEAN JOURNAL OF OPHTHALMOLOGY DOI 10.5301/ejo.5000921 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 92.3%
  20. 2017 Sequential development of dermatofibrosarcoma protuberans in the forehead and eyelid CANADIAN JOURNAL OF OPHTHALMOLOGY DOI 10.1016/j.jcjo.2017.04.007 YÖKSİS SJR Q2 JCR Q4 OpenAlex 55.2%

← Back to academicians